Lobbying

Campaign for Sustainable Drug Pricing's latest lobbying report covers Q4 2023, at $30K. Its first report covers Q4 2022; the issues it reports most are Copyright/Patent/Trademark and Medicare/Medicaid.

Campaign for Sustainable Drug Pricing

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Campaign for Sustainable Drug Pricing lobbying by quarter
Campaign for Sustainable Drug Pricing lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$30K1
Q2 2023$30K1
Q3 2023$30K1
Q4 2023$30K1
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Copyright, patent and trademark$50K · 5 reports
  • Medicare and Medicaid$50K · 5 reports
  • Pharmacy$50K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)5 reports
  • Health & Human Services, Dept of (HHS)5 reports
  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports
  • Food & Drug Administration (FDA)4 reports
  • Patent & Trademark Office (PTO)4 reports
  • Executive Office of the President (EOP)2 reports
  • White House Office1 reports

Firms it paid

Firm
McDermott+$150K5 quarters

Former officials lobbying for it

Former position
RODNEY WHITLOCK2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie NorwoodQ4 2023

Lobbying reports

Filed by
24/01/19for Q4 2023McDermott+$30K
23/10/16for Q3 2023McDermott+$30K
23/07/19for Q2 2023McDermott+$30K
23/04/20for Q1 2023McDermott+$30K
23/01/13for Q4 2022McDermott+$30K